The World Health Organisation recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...

Long-Term Support release, with features ranging from structured concurrency and compact object headers to ahead-of-time method profiling and JFR CPU-time profiling on Linux, is now generally ...

Kevin A. Schulman ([email protected]) is a professor of medicine at Stanford University, in Stanford, California. He is a board member and shareholder of Grid Therapeutics (an early stage ...

The Food and Drug Administration signed off on the first-ever weight-loss generic on Thursday, a knockoff of Novo Nordisk'sNVO Saxenda from Teva PharmaceuticalTEVA. Saxenda, the branded name for ...

Java is one of those OOPs based languages, along with Python and C++, that’s in demand right now. So, if you want to ride the bandwagon and use the language, you must download it on your system. Not ...

One of the world’s most sought-after drugs has officially become a vital medication. The World Health Organization has just added semaglutide—the active ingredient in Ozempic and Wegovy—to its list of ...

The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made ...

NEW DELHI, Sept 5 (Reuters) - The Netherlands is aiming to increase imports of Indian generic drugs into the country, as it looks to diversify its portfolio and avoid supply constraints, Dutch ...

AstraZeneca and MSD's PARP inhibitor Lynparza has improved long-term survival when given as adjuvant therapy for early breast cancer – the first drug in the class to show that in a clinical trial. The ...

NEW YORK (Reuters) -Some Chinese companies now racing to make generic versions of Novo Nordisk's Wegovy also supplied ingredients for more than a billion makeshift doses of weight-loss drugs sold ...

Last week, Natco Pharma filed six lawsuits in the Delhi High Court against Danish drugmaker Novo Nordisk for its popular anti-obesity drug semaglutide, sold as Wegovy in India. The Hyderabad-based ...